Original Research

Published on 02 Dec 2022

Multicenter, prospective feasibility study of Nano-Pulse Stimulation™ technology for the treatment of both nodular and superficial low-risk basal cell carcinoma

in Skin Cancer

Amy S. Ross
Todd Schlesinger
Christopher B. Harmon
Ronald L. Moy
Thomas E. Rohrer
Darius R. Mehregan
Richard Nuccitelli
Lauren Jauregui Johnston
William A. Knape

Frontiers in Oncology

doi 10.3389/fonc.2022.1044694

2,934 views
3 citations

Case Report

Published on 30 Nov 2022

Case Report: Durable complete pathologic response and organ preservation following ipilimumab and nivolumab for locally advanced primary vaginal mucosal melanoma

in Skin Cancer

Ahmad A. Tarhini
Wissam B. Hanayneh
John J. Powers
Carlos M. Moran Segura
Jose R. Conejo-Garcia
Cesar A. Lam
Ardeshir Hakam
Mitchel S. Hoffman

Frontiers in Oncology

doi 10.3389/fonc.2022.1044587

1,708 views
2 citations

Original Research

Published on 24 Nov 2022

Skin cancer outcomes and risk factors in renal transplant recipients: Analysis of organ procurement and transplantation network data from 2000 to 2021

in Skin Cancer

Xiaowei Hao
Wenhui Lai
Xinze Xia
Junnan Xu
Yangyang Wu
Chao Lv
Qingyang Meng
Kaikai Lv
Shuai Huang
Zhenjun Luo

Frontiers in Oncology

doi 10.3389/fonc.2022.1017498

4,455 views
8 citations

Brief Research Report

Published on 23 Nov 2022

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma

in Skin Cancer

Saba S. Shaikh
Yan Zang
Janel Hanmer
Hong Wang
Yan Lin
Diwakar Davar
Hassane M. Zarour
John M. Kirkwood
Yana G. Najjar

Frontiers in Oncology

doi 10.3389/fonc.2022.1022496

2,156 views
3 citations

Editorial

Published on 23 Nov 2022

Editorial: Role of pigmentation in melanoma

in Skin Cancer

Anna A. Brożyna
Laura Poliseno
Andrzej T. Slominski

Frontiers in Oncology

doi 10.3389/fonc.2022.1084717

1,082 views
1 citation

Original Research

Published on 22 Nov 2022

Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sections

in Skin Cancer

Katharina Kriegsmann
Frithjof Lobers
Christiane Zgorzelski
Jörg Kriegsmann
Charlotte Janßen
Rolf Rüdinger Meliß
Thomas Muley
Ulrich Sack
Georg Steinbuss
Mark Kriegsmann

Frontiers in Oncology

doi 10.3389/fonc.2022.1022967

3,028 views
6 citations

Mini Review

Published on 22 Nov 2022

The potential impact of melanosomal pH and metabolism on melanoma

in Skin Cancer

Jaewon You
Maftuna Yusupova
Jonathan H. Zippin

Frontiers in Oncology

doi 10.3389/fonc.2022.887770

3,033 views
2 citations

Review

Published on 17 Nov 2022

Immune checkpoint inhibitors for unresectable or metastatic pleomorphic dermal sarcomas

in Skin Cancer

Doris Helbig
Sebastian Klein

Frontiers in Oncology

doi 10.3389/fonc.2022.975342

3,034 views
7 citations

Case Report

Published on 17 Nov 2022

Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios

in Skin Cancer

Karam Khaddour
Alice Zhou
Omar H. Butt
Griffin Budde
Allyson Koyen Malashevich
George Ansstas

Frontiers in Oncology

doi 10.3389/fonc.2022.978996

2,012 views
4 citations

Original Research

Published on 14 Nov 2022

PCDH9 suppresses melanoma proliferation and cell migration

in Skin Cancer

Jiaojiao Zhang
Hui-Zhi Yang
Shuang Liu
Md Obaidul Islam
Yue Zhu
Zuhua Wang
RongYi Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.903554

2,340 views
2 citations

Original Research

Published on 07 Nov 2022

Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma

in Skin Cancer

Yajun Han
Qinqin Cai
Xiaolin Xie
Shilong Gao
Xiwen Fan

Frontiers in Oncology

doi 10.3389/fonc.2022.1011046

1,802 views
3 citations

Original Research

Published on 07 Nov 2022

Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients

in Skin Cancer

Ronen Stoff
Shirly Grynberg
Nethanel Asher
Shachar Laks
Yael Steinberg
Jacob Schachter
Ronnie Shapira-Frommer
Guy Ben-Betzalel

Frontiers in Oncology

doi 10.3389/fonc.2022.1020058

7,303 views
3 citations

Original Research

Published on 02 Nov 2022

A population-based cohort study for presence of ulceration among cutaneous malignant melanoma subgroups of patients

in Skin Cancer

Xinrui Li
Zichao Li
Xiaowei Yi
Xianchun Gao
Zhe Yang
Xingning Huang
Sijie Ma
Tianyuan Ma
Ziyi Deng
Lei Shang

Frontiers in Oncology

doi 10.3389/fonc.2022.929600

1,231 views
1 citation

Original Research

Published on 27 Oct 2022

Nomograms for predicting the prognosis of patients with penoscrotal extramammary Paget’s disease: A retrospective study in the SEER database and two medical centers

in Skin Cancer

Le-Bin Song
Xiang Zhou
Jiao-Chen Luan
Hao-Yang Wang
Xue-Chen Cao
Jia-Wei Lu
Yu-Jie Zheng
Xin-Feng Wu
Yan Lu

Frontiers in Oncology

doi 10.3389/fonc.2022.973579

1,477 views
2 citations

Original Research

Published on 20 Oct 2022

Methylation-driven gene DLL3 is a potential prognostic biomarker in ocular melanoma correlating with metastasis

in Skin Cancer

Ludi Yang
Gaoming Wang
Hanhan Shi
Shichong Jia
Jing Ruan
Ran Cui
Shengfang Ge

Frontiers in Oncology

doi 10.3389/fonc.2022.964902

2,012 views
3 citations

Original Research

Published on 17 Oct 2022

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma

in Skin Cancer

Joel Ho
Jane Mattei
Michael Tetzlaff
Michelle D. Williams
Michael A. Davies
Adi Diab
Isabella C. Glitza Oliva
Jennifer McQuade
Sapna P. Patel
Hussein Tawbi

Frontiers in Oncology

doi 10.3389/fonc.2022.1001150

5,888 views
21 citations

Navigation group

Articles

Multicenter, prospective feasibility study of Nano-Pulse Stimulation™ technology for the treatment of both nodular and superficial low-risk basal cell carcinoma

Case Report: Durable complete pathologic response and organ preservation following ipilimumab and nivolumab for locally advanced primary vaginal mucosal melanoma

Skin cancer outcomes and risk factors in renal transplant recipients: Analysis of organ procurement and transplantation network data from 2000 to 2021

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma

Editorial: Role of pigmentation in melanoma

Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sections

The potential impact of melanosomal pH and metabolism on melanoma

Immune checkpoint inhibitors for unresectable or metastatic pleomorphic dermal sarcomas

Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios

PCDH9 suppresses melanoma proliferation and cell migration

Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma

Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients

A population-based cohort study for presence of ulceration among cutaneous malignant melanoma subgroups of patients

Nomograms for predicting the prognosis of patients with penoscrotal extramammary Paget’s disease: A retrospective study in the SEER database and two medical centers

Methylation-driven gene DLL3 is a potential prognostic biomarker in ocular melanoma correlating with metastasis

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma